×
About 1,148 results

ALLMedicine™ Intestinal Perforation Center

Research & Reviews  398 results

Pneumatosis cystoides intestinalis accompanied by schistosomiasis: a case report.
https://doi.org/10.1177/03000605221105160
The Journal of International Medical Research; Yuan C, Teng F et. al.

Jun 21st, 2022 - Pneumatosis cystoides intestinalis (PCI) is a rare disease that most frequently occurs in the large and small intestine and has no obvious clinical symptoms. The main pathological feature is the presence of air-filled cysts in the intestinal submu...

Conservative treatment of gastric perforation after microwave ablation of a hepatocellu...
https://doi.org/10.1097/MD.0000000000029195
Medicine Roller J, Zimmer V et. al.

Jun 7th, 2022 - Microwave ablation (MWA) has been proven to be an efficient and safe method for local tumor control of liver tumors. Reported complications are rare, but include liver abscess, hematoma, pleural effusion, and occasional thermal injury of the adjac...

Sigmoid colon perforation in a SARS-CoV-2 positive neonate: a uniqueness report and a b...
https://doi.org/10.1186/s12887-022-03392-1 10.1136/bmjopen-2020-041247 10.1007/s12519-020-00392-y 10.1542/neo.22-5-e284 10.1016/j.epsc.2021.101807 10.1016/j.epsc.2020.101641 10.3389/fped.2020.00352 10.1097/00006454-200209000-00025
BMC Pediatrics; Jamali Z, Sinaei R et. al.

Jun 7th, 2022 - Despite the relative prevalence of small bowel and proximal colon perforation in the neonatal period, recto-sigmoid perforation is extremely rare. Full-term neonates experience intestinal perforation less frequently than premature infants. Here we...

Impact of Hindmilk on Weight Gain Among Moderate to Very Preterm Infants in Zambia
https://clinicaltrials.gov/ct2/show/NCT05403684

Jun 3rd, 2022 - The proposed study is a non-blinded randomized controlled trial with a 1:1 parallel allocation of infants to higher-volume feedings (200-240 ml/kg/day) or usual-volume feedings (140-180 ml/kg/day) using computer-generated random-block sequences. T...

Patent ductus arteriosus and spontaneous intestinal perforation in a cohort of preterm ...
https://doi.org/10.1038/s41372-022-01403-8 10.1016/S0022-3476(88)80285-3 10.1203/PDR.0b013e31818c7920 10.1542/peds.93.1.32 10.1055/s-0028-1103514 10.1007/s00383-002-0839-7 10.3233/NPM-16148 10.1016/S1072-7515(02)01344-3 10.1038/jp.2013.128 10.1136/archdischild-2011-300659 10.1053/j.semperi.2011.09.020 10.1038/jp.2010.3 10.1136/archdischild-2014-306214 10.1007/s00431-009-0983-3 10.1038/sj.jp.7211429 10.1038/sj.jp.7211506 10.1038/sj.jp.7210795 10.1056/NEJM200106283442602 10.1038/jp.2010.59 10.1056/NEJM200101113440203 10.1542/peds.2004-1159 10.1016/S0140-6736(04)17476-X 10.1542/peds.2014-0183 10.1001/jama.2018.1896 10.1016/j.phrs.2019.104418 10.1136/adc.2007.118117 10.1016/j.jpeds.2015.03.012 10.1038/jp.2010.199 10.1038/s41390-018-0077-x 10.1111/j.1651-2227.2008.00745.x 10.1136/adc.2007.133140 10.1136/adc.2007.119701 10.1038/pr.2016.148 10.1080/14767058.2019.1639661 10.3345/kjp.2018.07213 10.1055/s-0034-1393935 10.1136/adc.2010.185967 10.1016/j.jpeds.2015.09.028 10.1007/s00431-012-1851-0 10.1016/j.siny.2018.03.005 10.1053/j.semperi.2018.05.007 10.1016/0022-3468(91)90017-N 10.1016/S0022-3468(98)90475-4
Journal of Perinatology : Official Journal of the Califor... Mayer A, Francescato G et. al.

May 20th, 2022 - To assess whether either duration and magnitude of ductal shunt or medical treatment for patent ductus arteriosus (PDA) are related to spontaneous intestinal perforation (SIP). Clinical charts of infants <29 weeks' gestation born from 2006 to 2018...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  30 results

Impact of Hindmilk on Weight Gain Among Moderate to Very Preterm Infants in Zambia
https://clinicaltrials.gov/ct2/show/NCT05403684

Jun 3rd, 2022 - The proposed study is a non-blinded randomized controlled trial with a 1:1 parallel allocation of infants to higher-volume feedings (200-240 ml/kg/day) or usual-volume feedings (140-180 ml/kg/day) using computer-generated random-block sequences. T...

Noninferiority Trial of Liquid Human Milk Fortifier (HMF) Hydrolyzed Protein Versus Liquid HMF With Supplemental Liquid Protein
https://clinicaltrials.gov/ct2/show/NCT03001479

May 3rd, 2022 - All infants admitted to the Neonatal Intensive Care Unit (NICU) at Cardinal Glennon at gestational age <32 weeks and birthweight <1500g, and whose mothers intend to use breast milk (maternal or donor) will be approached for study participation. In...

Digital 3D Reconstruction Predicts Small Bowel Length
https://clinicaltrials.gov/ct2/show/NCT05338567

Apr 21st, 2022 - The prevalence of type 2 diabetes mellitus (T2DM) has been increasing annually worldwide, and the prevalence of diabetes has reached 11.6% in China. Laparoscopic Roux-en-Y gastric bypass (RYGB) is still widely accepted as a valid surgery in the tr...

NETs: Protection or Harm in Neonatal Inflammation or Infection
https://clinicaltrials.gov/ct2/show/NCT00747851

Apr 1st, 2022 - Many pediatric diseases including Systemic Inflammatory Response Syndrome (SIRS), sepsis, Acute Respiratory Distress Syndrome (ARDS) and neonatal Chronic Lung Disease (CLD) have been associated with dysregulation of the acute inflammatory response...

Probiotics Supplementation and Intestinal Microbiome in Neonates With Gastrointestinal Surgery
https://clinicaltrials.gov/ct2/show/NCT03266315

Jan 11th, 2022 - Research Objectives/Question: The main objective of this study is to determine the impact of probiotics administration on the intestinal microbiome in neonates undergoing gastrointestinal surgery. Primary question: Diversity and abundance of stool...

see more →

News  29 results

Preemies' Blood Type Tied to Risk for Serious Intestinal Infections
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/93461

Jul 7th, 2021 - AB blood type was associated with a higher risk for necrotizing enterocolitis (NEC) and focal intestinal perforation (FIP) in preterm infants, as compared with other blood types, a German population-based study found. Among very low birth weight i...

Prolonged Treatment With Bevacizumab Does Not Yield Further Survival Benefit in Ovarian Cancer
https://www.onclive.com/view/prolonged-treatment-with-bevacizumab-does-not-yield-further-survival-benefit-in-ovarian-cancer

Jun 7th, 2021 - Although prolonged treatment with bevacizumab (Avastin) for up to 30 months is feasible with consistent safety data for patients with primary epithelial ovarian, fallopian tube, or peritoneal cancer, the regimen did not improve survival over the s...

Durvalumab Use Differs in Real-World, PACIFIC Stage III NSCLC Populations
https://www.onclive.com/view/durvalumab-use-differs-in-real-world-pacific-stage-iii-nsclc-populations

Mar 27th, 2021 - More patients with stage III non–small cell lung cancer (NSCLC) received sequential chemoradiation (CRT) and delayed the time to durvalumab (Imfinzi) treatment in a real-world setting compared with those enrolled on the phase 3 PACIFIC trial, acco...

Olaparib Maintains Acceptable Safety Profile in Platinum-Sensitive, Relapsed Ovarian Cancer
https://www.onclive.com/view/olaparib-maintains-acceptable-safety-profile-in-platinum-sensitive-relapsed-ovarian-cancer

Mar 22nd, 2021 - Olaparib (Lynparza), when used in patients with platinum-sensitive relapsed ovarian cancer who had a known BRCA mutation and homologous recombination deficiency (HRD) status, demonstrated adverse effects (AEs) that proved to be consistent with the...

Lenvatinib and Pembrolizumab Combination Safe, Effective For Multiple Gastrointestinal Cancer Types
https://www.onclive.com/view/lenvatinib-and-pembrolizumab-combination-safe-effective-for-multiple-gastrointestinal-cancer-types

Jan 15th, 2021 - The combination of the anti-angiogenic multikinase inhibitor lenvatinib (Lenvima) plus the anti-PD-1 antibody pembrolizumab (Keytruda) demonstrated promising antitumor activity and a manageable safety profile in previously treated patients with ad...

see more →